Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 3Phase NA 1Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Bile Duct Neoplasms 3Pancreatic Neoplasms 2

Interventions

Oxaliplatin 21Capecitabine 19Fluorouracil 16Bevacizumab 16Esomeprazole 11Sorafenib 10Irinotecan 9Leucovorin 8Radiofrequency Ablation 7Propofol 7Bismuth 7Morphine 6Gemcitabine 6Folfox protocol 6Amoxicillin 6lenvatinib 5gadolinium ethoxybenzyl DTPA 5Tetracycline 5Sevoflurane 5S 1 (combination) 5Drug Therapy 5Control Groups 5Cisplatin 5sodium glycididazole 4fish oil triglycerides 4ferric carboxymaltose 4Sodium Chloride 4Ropivacaine 4Ribavirin 4Hepatectomy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Long-Term Synaptic Depression × Gastrointestinal × Clear all
NCT01256047 2020-02-18

Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy

Chiba University

Phase 4 Completed
40 enrolled
Gastrointestinal

Bile Duct Neoplasms

NCT01969110 2013-10-25

Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

Chiba University

Phase 4 Unknown
60 enrolled
Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms

NCT01256034 2012-10-23

EPIPD

Chiba University

Phase 4 Completed
50 enrolled 6 charts
Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡